Efficacy of a Once-Daily Formulation of Carvedilol for the Treatment of Hypertension

Journal of Clinical Hypertension

Volumn 8, Issue 12, 2006, Pages 840-849

  Weber, Michael A ^a   Bakris, George L ^b,e   Tarka, Elizabeth A ^c   Iyengar, Malini ^c   Fleck, Richard ^c   Sica, Domenic A ^d,e   Bodok Nutzati, Rebecca ^e   Buettner, Craig ^e   Calhoun, David A ^e   Capo, James P ^e   Cha, James Y M ^e   Cheung, Deanna G ^e   Chouinard, Guy ^e   Chrysant, Steven G ^e   Clark, James ^e   Conrad, Edward E ^e   Cook, Richard A ^e   Costa, Ralph F ^e   DeBusk, Charles H ^e   Denmark, Donald ^e   DuBois, Gustavo A ^e   Ducas, John ^e   Dure Smith, Belinda A ^e   Fuller, Gene R ^e   Gilderman, Larry L ^e   Graff, Alan ^e   Hack, Terrence C ^e   Harris, Duane J ^e   Heacock, James ^e   Johnson, Frank P ^e   Jones, Conigliaro ^e   Kaplan, Roy A ^e   Kereiakes, Dean J ^e   Kim, Ellen ^e   Klein, Eric J ^e   Koehler, Timothy M ^e   Lacourciere, Yves ^e   Lenis, Jacques ^e   Lesser, Michael P ^e   Lewin, Andrew J ^e   Lipetz, Robert S ^e   Littlejohn, Thomas Willard ^e   Lubin, Barry C ^e   Mark, George A ^e   Martin, Pierre ^e   McIlwain, Harris Hugh ^e   Misik, Karl ^e   Morin, David J ^e   Murray, R Michael ^e   Narayan, Puneet ^e   Neutel, Joel Michael ^e   Niederman, Alan L ^e   Ouellet, Jean Pascal ^e   Padget, Larry G ^e   Palchick, Bryce A ^e   Pesant, Yves ^e   Pullman, John ^e   Venkata S Ram, C ^e   Rosen, Jeffrey B ^e   Roth, Eli ^e   Rubino, John ^e   Santram, Deepak ^e   Schwartz, Robert L ^e   Senior, Richard ^e   Serfer, Gregory T ^e   St Amour, Eric ^e   St Hilaire, Richard ^e   Tamayo, Raul E ^e   Tonkon, Melvin J ^e   Toth, Phillip D ^e   Watson, Randall L ^e   Weinberg, Marc S ^e   Weinstein, Richard L ^e   Weiss, Robert J ^e   Yates, Scott W ^e   Zavoral, James H ^e   more..

^a SUNY Downstate Medical Center   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c GLAXOSMITHKLINE   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARVEDILOL; PLACEBO; ANTIHYPERTENSIVE AGENT; CARBAZOLE DERIVATIVE; PROPANOLAMINE DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PERIPHERAL EDEMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; BLOOD PRESSURE; CANADA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DELAYED RELEASE FORMULATION; DRUG ADMINISTRATION; MIDDLE AGED; PATHOPHYSIOLOGY; UNITED STATES;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CANADA; CARBAZOLES; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROPANOLAMINES; TREATMENT OUTCOME; UNITED STATES;

EID: 39049177405     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1524-6175.2006.05696.x     Document Type: Article

References (17)

1. Frishman WH, Sica DA. β-Adrenergic blockers. In: Izzo JL Jr, Black HR, eds. Hypertension Primer. 3rd ed. Dallas, TX: American Heart Association; 2003:417–421.
2. Packer M, Fowler MB, Roecker EB, et al., for the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group. Effect of carvedilol on morbidity of patients of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation. 2002;106:2194–2199.
3. Frishman WH. Postinfarction survival: role of β-adrenergic blockade. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia, PA: Lippincott Raven; 1996:1205–1214.
4. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–2572.
5. Lindholm LH, Carlberg B, Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet. 2005;366:1545–1553.
6. Ruffolo RR Jr, Boyle DA, Venuti RP, et al. Preclinical and clinical pharmacology of carvedilol. J Hum Hypertens. 1993;7(suppl 1):S2–S15.
7. Nichols AJ, Sulpizio AC, Ashton DJ, et al. In vitro pharmacologic profile of the novel beta-adrenoceptor antagonist and vasodilator, carvedilol. Pharmacology. 1989;39:327–336.
8. Ruffolo RR Jr, Gellai M, Hieble JP, et al. The pharmacology of carvedilol. Eur J Clin Pharmacol. 1990;38(suppl 2):S82–S88.
9. Nichols AJ, Gellai M, Ruffolo RR Jr. Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol. Fundam Clin Pharmacol. 1991;5:25–38.
10. Feuerstein GZ, Ruffolo RR Jr. Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection. Eur Heart J. 1995;16(suppl F):38–42.
11. Sung CP, Arleth AJ. Ohlstein EH. Carvedilol inhibits vascular smooth muscle cell proliferation. J Cardiovasc Pharmacol. 1993;21:221–227.
12. Bakris GL, Fonseca V, Katholi RE, et al, for the GEMINI Investigators. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA. 2004;292:2227–2236.
13. COREG (carvedilol) tablets [prescribing information]. GlaxoSmithKline, 2005.
14. Van Wijk BLG, Klungel OH, Heerdink ER, et al. Rate and determinants of 10-year persistence with antihypertensive drugs. J Hypertens. 2005;23:2101–2107.
15. Weber MA. Angiotensin II Receptor Blockers. In: Izzo JL Jr, Black HR, eds. Hypertension Primer. 2nd ed. Baltimore, MD: Lippincott; 1999:377–378.
16. Sica DA, Gehr TWB, Frishman WH. The renin-angiotensin axis: angiotensin converting enzyme inhibitors and angiotensin receptor blockers. In: Frishman W, Sonnenblick S, Sica DA, eds. Cardiovascular Pharmacotherapeutics. 2nd ed. New York, NY: McGraw-Hill; 2003:131–156.
17. Prisant ML. Calcium antagonists. In: Oparil S, Weber MA, eds. Hypertension: A Companion to Brenner and Rector's The Kidney. 2nd ed. Philadelphia, PA: Elsevier-Saunders; 2005:683–704.